Gene Therapy for IGHMBP2-Related Diseases
Clinical trial NCT05152823 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05152823
- Sponsor
- Megan Waldrop
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-04
- Primary completion
- 2028-07-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.